chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Priapism lasting 27 hours; This spontaneous case was reported by a physician and describes the occurrence of PRIAPISM (Priapism lasting 27 hours) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included GLIPIZIDE, METFORMIN, AMLODIPINE and HYDROCHLOROTHIAZIDE for an unknown indication.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced PRIAPISM (Priapism lasting 27 hours). At the time of the report, PRIAPISM (Priapism lasting 27 hours) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Apr-2021, Drug screen negative: unknown (Negative) Negative. On 17-Apr-2021, SARS-CoV-2 antibody test positive: unknown (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported. Test was reported to be repeated by 2 different labs and results were negative.Patient tested positive for Antibodies to COVID-19.
Employee received a Flu shot on 01/9/17 in her left upper deltoid IM in the Employee Health (EH) clinic. On 1/10/17 Employee returned to EH complaining of minor pain and swelling at the site. Nurse observed redness, minimum swelling and cool to touch at the site. Employee was provided with two instant ice packs with instruction to apply to site for twenty min. intervals. Employee voiced understanding of the instructions.
Patient reported hives that lasted for 48 hours after vaccination. Patient took Benadryl during that time.
Developed severe vertigo and lingering dizziness since 2/13 - it is now 5/13
4/9/21 seen in fast med for weakness lack of appetite, high pulse rate and no energy-put on bland diet 4/22/21 high pulse rate  telemed appt with GP then chest x-ray-interstitial lung disease - given perres and az pack 4/25/21 Emergency Department weakness, shortness of breath no appetite and groin pain. chest x-ray, chest with contrast- viral pneumonia.   2 IV anti biotics given erythromycin and ?, steroids' and amoxicillin to take home 5/10/21 Pulmonologist follow up appt-diagnosis side effects of vaccine. Could happen again with booster, see pulmonologist first  Healthy 58 yo female, bp 117/72  runs 8 miles a week and works 50 hours. Never gets sick ever
At 1300, pt reported itching and burning at the site and lip swelling was seen at the clinic. Was given Benadryl (50mg, q6hr prn per Dr.) and sent to the ER. ER gave prednisone and Benadryl. Is now exempt from receiving H1N1 in the future.
Red sore eyes and  some pain in arm  on October 2, 2019 at 5 pm.  No treatment. Pain in left arm and elbow on October 2, 2019 at 10 pm. Ibuprofen and Tylenol. Excruciating pain in left arm, elbow, shoulder, and spine and headache on October 3, 2019 at 8:30 pm.  Headache pain relief (acetaminophen 250 mg / aspirin 250 mg / caffeine 65) and  massage. Headache pain was relieved, left arm and shoulder pain relieved,  but still spine pain.  Right shoulder beginning to hurt as well.  Diclofenac Sodium Topical Gel 1%.  Less pain except for spine.
Information was received on 08-AUG-2017 from a lawyer regarding a case in litigation concerning a female patient of unknown age. The patient was inoculated with a dose of ZOSTAVAX on or about 15-DEC-2015 at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevents shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 16-JUL-2016, the patient was treated at a clinic for the onset of a severe vesicular rash accompanied by a weakened immune systems, which was diagnosed as  herpes zoster, or shingles. On or about 26-JUL-2016, the patient received subsequent treatment at a physician's office for ongoing and worsening shingles symptoms. The patient has been prescribed gabapentin (manufacturer unknown) for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a direct and proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Lost the hearing completely; This case was reported by a consumer via interactive digital media and described the occurrence of hearing loss in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced hearing loss (serious criteria GSK medically significant). On an unknown date, the outcome of the hearing loss was unknown.   The reporter considered the hearing loss to be related to Shingles vaccine.  Additional details were provided are as follows: The case was reported for reporter's sister. The age at vaccination was not reported. The patient lost the hearing completely in one ear after taking the vaccine. The reporter reported that there was hearing loss associated with the vaccine. The follow-up could not be possible as no contact details were available.
The night after my vaccine I experienced numbness and tingling in my hands and feet. The following days after that for over a week I had numbness tingling and weakness in my right side( arm and leg) .
This spontaneous report was received from nurse practitioner referring to patient of unknown age and gender. No pertinent medical history and concurrent conditions reported. On 23-JUL-2014 the patient received improperly stored with MMR II [lot # J10993 expiry date 13-SEP-2015], exposed to 9.7 degree for 6 hours 20 minutes, subcutaneously (dose not reported). No other concomitant therapies reported. No adverse effects reported. The outcome of the events was unknown. No PQC reported. The case has been linked with cases 1407USA012136, 1407USA014427, 1407USA014428, 1407USA014429, 1407USA014430, 1408USA000005, 1408USA000006, 1408USA000009, 1408USA000012, 1408USA000013, 1408USA000015, 1408USA000832, 1408USA000838, 1408USA000843, 1408USA000848 and 1408USA000853. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 04-NOV-2012 at 21:12, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0365AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Nausea, no energy , in bed all day, sore arm at injection site  Just like Covid  systoms
Patient is fully vaccination.  COVID positive on 11/15/2021.  Hospitalized 11/20 to 11/25, 2021.  Patient is a known case of high blood pressure presented to the hospital with acute respiratory failure related to COVID-19.Treated with IV remdesivir with IV steroid and breathing treatments. Patient's electrolytes replaced.  Patient developed acute kidney injury.  72-year-old male, history of CAD GERD hyperlipidemia presented to the ED with shortness of breath.
1) 3/31/2021 at 3:00 AM I felt -  rush of fluid like substance up my spine and into my head; -  headache - runny nose & cough -  bodywide - over all body- intense itching that continued for 6 hours 2) 04/06/2021  at 6PM in the evening - welts - I inch wide and high - arose around my entire waist;  - intense itching in my torso for 6 hours 3) 3/15/2021 to present I have not been able to work - UNEMPLOYMENT - EXTREME FATIGUE, fatigue so deep I have been in bed most all of the time - causing me to not be able to work nor to do simple activities of daily living - cooking, cleaning etc.
FRIEND REPORTED PATIENT WAS DX WITH COVID ON 1/25/2021 - SAME DAY AS HER VACCINE
No adverse events, Patient came for 2nd dose of Covid vaccine RN gave second dose of Pfizer Patient reported getting 1st dose around 06/2021 of Moderna
Sinus/ear pressure and ear discomfort/pain. 2 short mild instances of tinnitus. Each lasted about 5 seconds then went away. One was in left ear, one in right. Head and ear pressure have gotten much better since first onset, but still comes and goes, not totally resolved.
Ringing sensations in both ears/Aggravated ringing in ears; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing sensations in both ears/Aggravated ringing in ears) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, the patient experienced TINNITUS (Ringing sensations in both ears/Aggravated ringing in ears). At the time of the report, TINNITUS (Ringing sensations in both ears/Aggravated ringing in ears) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included- Blood pressure medicine No treatment reported.
INJURY FROM VACCINE; This spontaneous report received from a consumer via a company representative concerned multiple patients. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced injury from vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of injury from vaccine was not reported. This report was non-serious.
Injection at 9:45am December 3, fatigue/arm sore by 6pm. Awoke to 101.6 fever at 2:30am Dec 7, with chills, body aches, joint pain, nausea, vomiting, disorientation,  and headache. Nausea went away after violently vomiting around 3:15am, all other symptoms remained until december 6. Fever lowered to 99.9 on Dec 6, headache progressed into full blown migraine. Had to call in sick to work and stay in bed all day. December 7 slight headache but brain fog/grogginess remain. Temperature now down to 99.3, but feel weird still. Fatigue along with wooziness(?) Unsafe to drive, turning head quickly results in nausea. Assumed I was just unlucky with side effects so didn't seek medical attention other than from friend who's had migraines before. The only other time I've gotten one was on the second booster shot for covid-19 in April 2021. Booster shots giving me migraines for the first time is terrifying. Do not recommend.
Arm and shoulder pain was mild/sore arm and whole shoulder after first dose; Headache after first dose; Arm and shoulder pain was mild/sore arm and whole shoulder after first dose; This is a spontaneous report from a contactable consumer (patient) or other non-health care professional. A 38-year-old male patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6206) via an unspecified route of administration, administered in left arm on 12Mar2021 (at the age of 38-year-old) as dose 1, single for covid-19 immunization. Medical history reported as No. The patient's concomitant medications were not reported. Additional vaccines was not administered on same date of the Pfizer suspect. On 12Mar2021 the patient experienced arm and shoulder pain was mild/sore arm and whole shoulder after first dose, headache after first dose. Caller lost his father 2 weeks before he received his vaccine. It was motivation, for himself and his family to get the vaccine. Emergency room, physician office visit reported as no. Relevant Tests reported as no. Outcome of the event Arm and shoulder pain was mild/sore arm and whole shoulder after first dose resolved on 16Mar2021 and outcome of the event Headache after first dose was resolved on 13Mar2021.  No follow-up attempts are needed. No further information is expected.
School Clinic: At bedtime post vax pt noticed redness, swelling (4x5 in) with soreness in right arm.  He put ice on the site and took two Tylenol.  Wednesday, he complained of sore arm and swelling. Thursday continued to complain of sore arm, swelling.  Mom helped him dress, they gave Tylenol with ice at school. Friday he dressed himself, swelling of arm the same. Patient can move arm but very uncomfortable. Good strength Friday, patient has a history of allergies but better this past year with puberty. The patient has been seen in the allergy clinic. Has epinephrine on hand if needed. 05/16 everything "OK."
Sweating, Chills, nausea, weakness, lethargic, runny nose and itchy throat
generalized pain; headache; fever of 100.5; pain in the joints of the fingers and neck; neuropathy of feet. Side effects subsiding over 24 hours
Pfizer-BioNTech COVID-19 Vaccine EUA Low grade fever and chills first night Body aches first day Lymph node soreness under left arm (injection arm) second day. No fever, no body aches second day.
Patient started to feel as if an asthma attack was starting, used her rescue inhaler, but throat still felt like it was swollen,  able to swallow, administered 25mg benedryl PO,  took vital signs,  BP 140/110, R 22, P 100.  After 5 minutes, patient stated her throat felt like it was not continuing to swell, still had cough, but no other signs/symptoms of worsening or anaphylactic reaction.  Site of injection with no redness or swelling.  Contacted patient's medical provider, who got her into the office immediately.
No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 54-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 02-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used).    No concomitant medications details were reported.  Patient received vaccine at Pharmacy.  Beyond use date of the vaccine was 17-Feb-2022.  No treatment medications details were reported.  NDC number was reported as 80777-273-10.   This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704416:Master case
Patient was administered an invalid dose of Moderna COVID-19 bivalent booster/ Recipients received underdose of 0.25 Moderna Bivalent Booster; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient was administered an invalid dose of Moderna COVID-19 bivalent booster/ Recipients received underdose of 0.25 Moderna Bivalent Booster) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Patient was administered an invalid dose of Moderna COVID-19 bivalent booster/ Recipients received underdose of 0.25 Moderna Bivalent Booster) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient was administered an invalid dose of Moderna COVID-19 bivalent booster/ Recipients received underdose of 0.25 Moderna Bivalent Booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient was administered an invalid dose of Moderna COVID-19 bivalent booster/ Recipients received underdose of 0.25 Moderna Bivalent Booster).    No concomitant product reported by reporter. It was reported that 100 patients were administered an invalid dose of Moderna COVID-19 bivalent booster. The nurse had no standing order other than what they had for second booster, when administering bivalent boosters, so they assumed same dose as second booster and administered 0.25mL to uncompromised adults. This case was for one of the patient among the 100 patients who were administered an invalid dose of Moderna COVID-19 bivalent booster.  It was reported that CDC had recommended to revaccinate the patients with full dose of 0.5mL. No treatment medication reported by reporter.
Hospitalized: 4 days of COVID-19 infection with increased dyspnea and lethargy. Lobar pneumonia probably aspiration not COVID-19 related.
w/in 24hr of vax pt devel fever, myalgia, arthralgias & an inj site rxn characterized by a 3.5inch area of redness, warmth & swelling;pt recovered p/4 days;this is 1 of 5 pt from this facility to have an adverse exp p/vax;
Caller reports that client's face turned red, eyelids swollen, itching of face and arms. Began approximately 15 hours post vax. No fever. Was given antihistamine by a physician who was a neighbor with effect.
presented to the Covid vaccine clinic and he thought he received Moderna for his first dose mid January. He was overdue for his second dose and the original facility was unable to get him scheduled for his second dose for over 60 days so he decided to find a vaccine clinic where he could get his second vaccine dose.  He presented to the intake team and the person who was to administer the vaccine and filled out appropriate forms stating that he had a first dose of what he thought was Moderna elsewhere.  I was the one entering the vaccines and when his chart was refreshed the previous Pfizer vaccine showed up (after he received the Moderna dose).   I discussed this with him. He has not had adverse effects.   He was given the Pfizer dose on 1/18 and received Moderna dose at our clinic on 4/17. I recommended he have his antibodies tested and likely he will not need further Covid vaccines unless a booster is created.
5/10/2013 1:39pm: Mom noticed patients lips swollen 50 minutes following receiving vaccine (1/2 way through lunch, no new foods that Mom know of, no new foods). Benadryl given by mom at approximately 12:45pm.
Site: Bruising at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: see additional details below-Severe, Additional Details: pt moved during injectin. when needle was retracted, visible raised bump the size of a nickel. tehnician gave the injection, notified rph on duty immediately, rph removed bandaid to inspect site, told pt will experience brusing and swelling, take ibuprofen and monitor. sit for 15 minutes, call pharmacy within next hour if site worsens. go to er if pain/fever/cannot feel arm.
Anaphylaxis: Closing throat, swollen mouth, sore throat, difficulty swallowing, difficulty breathing deeply, itchiness in mouth, blotching of skin
red, swollen, warm  to touch right arm reported next day (1-21-2020) , redness was gone by  01/25/2020 on its own . But still a little warm and light red color more like a pink patch
Swelling in arm below injection site; Red on arm; Rash on arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling in arm below injection site), VACCINATION SITE ERYTHEMA (Red on arm) and VACCINATION SITE RASH (Rash on arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011m2da) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included METFORMIN and VITAMINS NOS for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Swelling in arm below injection site), VACCINATION SITE ERYTHEMA (Red on arm) and VACCINATION SITE RASH (Rash on arm). At the time of the report, VACCINATION SITE SWELLING (Swelling in arm below injection site), VACCINATION SITE ERYTHEMA (Red on arm) and VACCINATION SITE RASH (Rash on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant product included medications for blood pressure. Treatment information was not provided.
Started experiencing  fatigue the next day.  Had to leave work early, , had nausea, chills, fever, joint pain, headache.  Slept for 19 hours. Headache continues into following day, but fever gone, still fatigued.